March 24 (Reuters) - China-based United Laboratories
International ( ULIHF ) said on Monday it will license its
weight-loss drug candidate to Danish drugmaker Novo Nordisk
in a deal worth up to $2 billion.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini
Ganguli)